Bliss GVS Pharma Limited announced on June 02, 2026, that its manufacturing facility located in Palghar, Maharashtra, has received an Inspection Closure Report from the World Health Organization (WHO), Geneva. The report confirms that the facility is in compliance with the Good Manufacturing Practices (GMP) standards published by the WHO. This achievement highlights the company's dedication to quality assurance, safety, and operational excellence in its manufacturing processes.
